Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForterra Regulatory News (FORT)

Share Price Information for Forterra (FORT)

Share Price is delayed by 15 minutes
Get Live Data
138.20    1.40 (1.02%)
Bid:
137.80
Ask:
138.40
Spread: 0.60 (0.435%)
Market Cap: £283.44m
FORT Live PriceLast checked at - London Stock Exchange

Intraday Forterra Share Chart

Trading update

22 Nov 2017 07:00

RNS Number : 1437X
Forterra plc
22 November 2017
Β 

Β 

22 November 2017

Forterra plc

Trading update

Β 

Forterra plc, a leading UK producer of manufactured masonry products, provides this trading update covering the period from 1 July to 31 October 2017.

Β 

Trading in the period has continued to be underpinned by good activity levels in the new build residential sector, resulting in double digit growth of brick and aggregate block volumes for the ten months to October 2017 compared with the same period last year. Overall Group revenue for the ten month period was 12% ahead of last year after excluding the Bison acquisition.

Β 

The Group completed the acquisition of the trade and certain assets of Bison Manufacturing Ltd in September 2017. The integration of the business, which includes the transfer of certain product lines between the two existing Forterra precast concrete facilities and the new Bison facility in order to improve efficiency and maximise potential, is progressing to plan. The Group's precast concrete business has been rebranded as Bison Precast, recognising the strength of the Bison brand in the marketplace.

Β 

Following the completion of the investment project at the Group's Claughton brick facility in Lancashire resulting in an increased capacity of over 5 million bricks per annum (c11% of the existing plant capacity), production commenced in the second half in line with plan. A kiln at the nearby Accrington facility has been relit and the plant is expected to build up to full production utilising both kilns during 2018.

Β 

The Group continues to generate a strong level of operating cashflow and this, after the payment of Β£20m for the Bison acquisition and dividends of Β£13.8m, resulted in net debt of Β£87.2m at 31 October 2017 compared with Β£92.3m at the start of the year.

Β 

Based on the good trading performance in the year to date and the forward order book, the Board's expectations for the full year remain unchanged.

Β 

Β 

Enquiries

Forterra plc:

+44 (0) 1604 707 600

Stephen Harrison (CEO)

Shatish Dasani (CFO)

FTI Consulting:

+44 (0) 20 3727 1340

Richard Mountain

Nick Hasell

Β 

Β 

Further information relating to the Company and its group can be found at www.forterraplc.co.uk

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTBUBDBRDDBGRB
Date   Source Headline
18th Feb 20262:27 pmRNSEmployee Benefit Trust Share Purchase
3rd Feb 202612:26 pmRNSEmployee Benefit Trust Share Purchase
29th Jan 20268:33 amRNSHolding(s) in Company
28th Jan 20269:21 amRNSHolding(s) in Company
26th Jan 20264:07 pmRNSHolding(s) in Company
22nd Jan 20267:00 amRNSFull Year 2025 Trading Update
20th Jan 20267:00 amRNSEmployee Benefit Trust Share Purchase
7th Jan 20269:39 amRNSEmployee Benefit Trust Share Purchase
2nd Dec 20259:22 amRNSEmployee Benefit Trust Share Purchase
24th Nov 20259:03 amRNSHolding(s) in Company
20th Nov 20259:13 amRNSHolding(s) in Company
18th Nov 20255:03 pmRNSEmployee Benefit Trust Share Purchase
11th Nov 20257:00 amRNSTrading Update
4th Nov 20254:34 pmRNSEmployee Benefit Trust Share Purchase
24th Oct 20251:36 pmRNSHolding(s) in Company
23rd Oct 20251:21 pmRNSDirector/PDMR Shareholding
17th Oct 20259:58 amRNSEmployee Benefit Trust Share Purchase
14th Oct 20259:06 amRNSHolding(s) in Company
13th Oct 202510:15 amRNSEmployee Benefit Trust Share Purchase
2nd Oct 20252:54 pmRNSGrant of Options under 2025 SAYE Scheme
11th Aug 20251:15 pmRNSHolding(s) in Company
29th Jul 20257:38 amRNS-RProgressive publishes new research
29th Jul 20257:00 amRNSSix months ended 30 June 2025
23rd Jul 202510:05 amRNSHolding(s) in Company
19th Jun 20257:05 amRNSDirector Declaration
20th May 20251:47 pmRNSAnnual General Meeting 2025 Results
20th May 20257:43 amRNS-RProgressive publishes new research
20th May 20257:00 amRNSAGM Trading Update
13th May 202510:36 amRNSHolding(s) in Company
11th Apr 20259:18 amRNSDirector / PCA Shareholdings
2nd Apr 20252:22 pmRNSDirector/PDMR Shareholding
26th Mar 20255:53 pmRNSAnnual Report & Accounts 2024 & Notice of AGM 2025
25th Mar 20251:47 pmRNSDirector/PDMR Shareholding
20th Mar 20252:44 pmRNSHolding(s) in Company
20th Mar 20257:00 amRNSGrant under Performance Share Plan
20th Mar 20257:00 amRNSGrant under Deferred Annual Bonus Plan
18th Mar 20252:23 pmRNSHolding(s) in Company
12th Mar 20258:14 amRNS-RProgressive publishes new research
12th Mar 20257:00 amRNSFull Year Results
6th Mar 20257:00 amRNSAppointment of Independent Non-Executive Director
27th Feb 20253:35 pmRNSHolding(s) in Company
26th Feb 20252:50 pmRNSHolding(s) in Company
4th Feb 20257:00 amRNSDirectorate Change
23rd Jan 20257:00 amRNSFull Year 2024 Trading Update
6th Jan 20259:23 amRNSHolding(s) in Company
2nd Jan 202511:38 amRNSDirector/PDMR Shareholding
11th Nov 20247:00 amRNSTrading update to the end of the October
4th Nov 202410:24 amRNSHolding(s) in Company
30th Oct 20244:54 pmRNSHolding(s) in Company
28th Oct 202411:51 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.